Jan. 4, 2023

Understanding Waldenström Macroglobulinemia

Understanding Waldenström Macroglobulinemia
Understanding Waldenström Macroglobulinemia
Treating Blood Cancers
Understanding Waldenström Macroglobulinemia
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts TuneIn podcast player icon TuneIn TuneIn Spotify podcast player icon Spotify Spotify Amazon Music podcast player icon Amazon Music Amazon Music Deezer podcast player icon Deezer Deezer
Apple Podcasts podcast player icon Apple Podcasts Apple Podcasts TuneIn podcast player icon TuneIn TuneIn Spotify podcast player icon Spotify Spotify Amazon Music podcast player icon Amazon Music Amazon Music Deezer podcast player icon Deezer Deezer

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA

Recorded on December 6, 2022


Shayna Sarosiek, MD
Shayna Sarosiek, MD
Assistant Professor
Harvard Medical School
Dana Farber Cancer Institute
Boston, MA
Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic factors? Dr. Shayna Sarosiek, from the Dana-Farber Cancer Institute, joins us to provide a deep dive into WM, including testing, monitoring, treatment updates, clinical trials, and so much more. Tune in today!

This activity is developed through a collaboration with the International Waldenström’s Macroglobulinemia Foundation.